The use of expanded criteria cadaver and live donor kidneys for transplantation

Urologic Clinics of North America

Volumn 28, Issue 4, 2001, Pages 687-707

  Modlin, C S ^a   Goldfarb, D A ^a   Novick, A C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; CADAVER DONOR; CANCER PATIENT; CHILD; DIABETES MELLITUS; GERIATRIC PATIENT; GLOMERULONEPHRITIS; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; URETER MALFORMATION; VIRUS HEPATITIS;

EID: 0035666939     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(01)80026-4     Document Type: Article

References (157)

1. Fate of transplanted kidneys with diabetic nephropathy
2. Marginal donors: A viable solution for organ shortage
3. Transplantation of single pediatric cadaveric kidneys into adult recipients after prolonged preservation
4. Transplantation of single pediatric cadaver kidneys into adult recipients
5. Utilization of cadaveric kidneys from donors with reactive hepatitis C virus antibody or reactive hepatitis B core antibody
6. Use of "marginal" donors for organ transplantation
7. The use of marginal donors for organ transplantation: The older and younger donors
8. Living unrelated kidney transplantation: A 12 year single center experience
9. Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants
10. When should expanded criteria donor kidneys be used for single versus dual kidneys transplants?
11. Short and long-term results with kidneys from non-heart beating donors
12. Metabolic requirements for successful extended hypothermic kidney preservation
13. Renal transplantation from a donor over 60 years old
14. Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft loss
15. 96-Hour renal preservation with silica gel precipitated plasma cold storage versus pulsatile perfusion
16. Cadaveric kidneys for transplantation: A paradox of shortage in the face of plenty
17. Renal transplantation
18. Aging living donor: The best source for kidney transplantation?
19. Evaluation of living renal donors: The current practice of US transplant centers
20. Outcome of renal transplantation from elderly donors
21. Renal transplantation from living related donor after excision of angiomyolipoma for the donor kidney
22. Kidney preservation ex vivo for transplantation
23. Kidney transplantation: The use of abnormal kidneys
24. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging renal ablation and intrinsic renal disease
25. Transplantation of horseshoe kidney into a single recipient
26. National impact of pulsatile perfusion on cadaveric kidney transplantation
27. Analysis of cadaver donor criteria on the kidney transplant survival rate in 5129 transplantations
28. Are kidneys from non-heart beating donors second class organs?
29. Delayed graft function adversely affects one-year graft survival of cadaveric renal transplants
30. Clinical significance of the 1-hour biopsy in renal transplantation
31. Microvascular reconstructive "bench" surgery for donor kidneys before transplantation: Techniques and results
32. Should excessive height and weight differences between the kidney donor and recipient be avoided?
33. Prediction of creatinine clearance from serum creatinine
34. Incidental fibromuscular dysplasia in potential renal donors: Long-term clinical follow-up
35. Morphologic findings in "zero hour" biopsies of renal transplants
36. Effect of donor age on renal allograft survival
37. Organ donor screening for infectious diseases
38. Use of an autogenous hypogastric artery patch graft for living related donor kidneys with multiple renal arteries
39. Donor-recipient age differencean independent risk factor in cyclosporine treated renal transplant recipients
40. The actual and potential supply of organ donors in the United States
41. Is chronic renal transplant rejection a non-immunological phenomenon?
42. Delayed function reduces renal-allograft survival independent of acute rejection
43. Long term function and survival rates of kidneys from extreme age donors in the cyclosporine era
44. Controversies in organ donation: Minority donation and living unrelated renal donors
45. Kidneys from living donors with renal vascular disease may be safely used for transplantation
46. Glomerulosclerosis as a determinant of post-transplant function of older donor renal allografts
47. Comparison of static versus pulsatile preservation of matched paired kidneys
48. Long-term outcome of kidney transplantation from expanded criteria donors: A single center experience
49. Successful transplant of kidneys with diffuse diabetic glomerulosclerosis
50. A good alternative to reduce the kidney shortage: Kidneys from non-heart beating donors
51. Transplanted infections: Donor-to-host transmission with the allograft
52. Organ transplantation from victims of carbon monoxide poisoning
53. Single kidney transplants from donors with low estimated creatinine clearance
54. Relevance of urine cultures in the evaluation of potential cadaver kidney donors
55. The transplantation of difficult donor kidneys and recipients: Helpful surgical techniques
56. Non-heart beating donors: Methods and techniques
57. Long-term results transplanting pediatric en bloc cadaveric kidneys into adult recipients
58. Antibody to hepatitis B core antigen
59. Influence of cadaver donor age on the success of kidney transplants
60. The donor organ shortage in the Balkans: Accept everyone
61. Costs associated with expanding donor criteria: A collaborative statewide prospective study
62. Double renal transplants from marginal donors: 2-Year results
63. Ten years of experience with vascular complications in renal transplantation
64. High risk donors: Expanding donor criteria
65. Impact of donor age on long-term graft survival in living donor kidney transplantation
66. Age related incidence of sclerotic glomeruli in human kidneys
67. Long-term follow-up of ABO-incompatible renal transplant recipients
68. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients
69. Should hepatitis C infected kidneys be transplanted in the United States?
70. Viability assessment of non-heart beating donor kidneys by alpha glutathione S-transferase in the machine perfusate
71. Clinical outcome of cadaveric renal transplantation using "marginal donors"
72. Transplantation of a horseshoe kidney en bloc
73. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors
74. Use of inferior epigastric artery for reconstruction of a small accessory renal artery in renal transplantation
75. Statement on non-heart beating donor programs
76. Twenty percent more kidneys through a non-heart beating program
77. Long-term function and survival of elderly donor kidneys transplanted into young adults
78. Transplantation of elderly donor kidneys into young adults
79. Utilization of the older donor for renal transplantation
80. The kidneys that nobody wanted: Support for the utilization of expanded criteria donors
81. Transplantation of kidneys with fibromuscular dysplasia
82. The evaluation of the living renal donor, surgical techniques and results
83. Identification of donor factors predisposing to high discard rates of cadaver kidneys and increased graft loss within one year post-transplant
84. Transplantation of microbially contaminated cadaver kidneys
85. Transplant of a polycystic kidney because of organ shortage
86. Cadaver kidney transplantation using donors with hypertension in the North Italy transplant program
87. Evaluation of the factors related to early graft function in 90 kidney transplants from non-heart beating donors
88. Transplantation of a horseshoe kidney
89. Successful homotransplantation of the human kidney between identical twins
90. Clinical evaluation of donor renal artery reconstruction in kidney transplantation
91. Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation
92. Long-term results with single pediatric donor kidney transplants in adult recipients
93. Kidney transplantation and donor age
94. Estimation and characterization of the potential organ donor pool in Pennsylvania: Report of the Pennsylvania Statewide Donor Study
95. Successful renal transplantation from non-heart beating donors with a high creatinine
96. Eversion endarterectomy of the cadaver donor renal artery: A method to increase the use of elderly donor kidney allografts
97. Comparison of the results of renal transplants from conventional and non-heart beating cadaveric donors
98. The effect of increased donor age on kidney-transplant outcome
99. Donor cultures reported positive after transplantation: A clinical dilemma
100. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors
101. Successful use of kidneys from diabetic cadaver kidney donors: 67 and 44 month graft survival
102. Kidney transplants with positive anti-hepatitis C virus donors
103. Issues of informed consent and access to extended donor pool kidneys
104. Single center experience of unrelated living donor renal transplantation in the cyclosporine era
105. Experience with anencephalic infants as prospective organ donors
106. Renal transplantation in patients positive for hepatitis B or C
107. Living unrelated renal transplantation: Results in 40 patients
108. Impact of donor age and quality of donor kidneys on graft survival
109. Survival and function of a renal graft from a marginal cadaver donor
110. Pulsatile preservation characteristics predict early graft function in extended criteria donor kidneys
111. Transplantation of kidneys from hypertensive donors
112. Transplantation of kidneys from expanded criteria donors
113. Intractable renovascular hypertension in an adult recipient of a pediatric cadaver renal transplant
114. Report on evaluating the potential organ donor pool in Kentucky
115. Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate
116. The high cost of delayed graft function in cadaveric renal transplantation
117. Transplantation of cadaver kidneys from a donor with crossed nonfused renal ectopia
118. Extending the criteria for cadaver kidney donors
119. The impact of hepatitis C virus (HCV) on the potential renal allograft recipient
120. Fate of four cadaveric donor renal allografts with mesangial IgA depots
121. Outcome of en bloc and single kidney transplantation from very young cadaveric donors
122. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors
123. Risk evaluation in the use of kidneys from elder organ donors for transplantation
124. A retrospective study of kidney transplant recipients from living unrelated donors
125. Use of split horseshoe kidney for transplantation
126. Differential kidney scans in preoperative evaluation of kidney donors
127. Long-term allograft survival in renal transplantation from elderly donors
128. Patient acceptance of cadaveric kidneys from expanded criteria donors
129. The potential for elderly donors to increase renal transplantation rates in Australia
130. Cadaver kidney donors with hypertensive histories
131. Renal transplantation with limit donors: To what should the good results obtained be attributed?
132. Donor age and cumulative kidney graft survival
133. Successful use of cadaver kidneys from diabetic donors for transplantation
134. Successful use of polycystic cadaver donor kidneys
135. The successful use of marginal cadaveric donor kidneys
136. Results and significance of angiography in potential kidney donors
137. Preliminary experience with double kidney transplants from adult cadaveric donors: Analysis of United Network for Organ Sharing data
138. Extended cadaver renal preservation with combined simple cold storage and hypothermic pulsatile perfusion
139. The hyperfiltration hypothesis in human renal transplantation
140. Pulsatile kidney perfusion for preservation and evaluation: Use of high risk kidney donors to expand the donor pool
141. Transplantation of adult and pediatric horseshoe kidneys
142. IgA nephropathy in HLA-identical siblings
143. Organ procurement from non-heart beating donors by total body cooling
144. Procurement, preservation and transport of cadaver kidneys
145. Effect of warm ischemia time and HLA (A and B) matching on renal cadaveric graft survival and rejection episodes
146. The influence of donor age on graft survival
147. Kidney retrieval from asystolic donors: A valuable source of additional organs
148. Transplantation of adult and pediatric horseshoe kidneys: Comment
149. The risk of transmission of hepatitis B from HbsAg(3), HbcAb(+), HBIgM(-) organ donors
150. Use of radiographically abnormal kidneys in living related donor renal transplantation
151. Transplantation of infected kidneys: Clinical and experimental results
152. Clinical and economic outcomes of expanded criteria donors in renal transplantation
153. Economic costs of expanded criteria donors in renal transplantation
154. Use of kidneys from older cadaver donors for renal transplantation
155. Factors affecting graft function in cadaveric renal transplantation from non-heart beating donors using a double balloon catheter
156. Marginal kidney graft function from non-heart beating donors